Community Pharmacists' Views and Practices Regarding Natural Health Products Sold in Community Pharmacies.
BACKGROUND
Reports of regulatory and evidentiary gaps have raised concerns about the marketing and use of natural health products (NHPs). The majority of NHPs offered for sale are purchased at a community pharmacy and pharmacists are "front-line" health professionals involved in the marketing and provision of NHPs. To date, the involvement of pharmacists in pharmacy care involving NHPs and the degree to which concerns over the safety, efficacy, marketing and regulation of NHPs are addressed in pharmacy care in Canada have not been studied.


METHODS
Using Qualtrics, a web-based data collection and analysis software, and a study instrument made up of fifteen (15) open-ended, closed and rating scale questions, we surveyed the attitudes and practices of 403 community pharmacists in the Canadian province of Alberta regarding NHPs offered for sale in community pharmacies.


RESULTS
The majority of pharmacists surveyed (276; 68%) recommend NHPs to clients sometimes to very often. Vitamin D, calcium, multivitamins, prenatal vitamins, probiotics and fish oil and omega-3 fatty acids were the most frequently recommended NHPs. The most common indications for which NHPs are recommended include bone and musculoskeletal disorders, maintenance of general health, gastrointestinal disorders and pregnancy. Review articles published in the Pharmacist's Letter and Canadian Pharmacists Journal were the primary basis for recommending NHPs. The majority of pharmacists surveyed (339; 84%) recommend the use of NHPs concurrently with conventional drugs, while a significant number and proportion (125; 31%) recommend alternative use. Pharmacists in the study overwhelmingly reported providing counselling on NHPs to clients based on information obtained mainly from the Natural Medicines Comprehensive Database.


CONCLUSIONS
The study findings indicate a high prevalence of pharmacy care relating to NHPs among study participants. Although pharmacists' practices around NHPs are consistent with the existing licensing framework, we found some involvement in problematic practices that necessitate further research and potential policy scrutiny. The study also uncovered patterns of recommendations, including sources relied on in recommending NHPs and in providing counselling to patients, that raise concerns about the quality and credibility of NHP-related care provided to pharmacy patrons.
Faculty of Law, University of Alberta, Edmonton, Alberta, Canada.|Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Ubaka
http://orcid.org/0000-0001-7764-6799
U
Ogbogu
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Candace
C
Necyk
Int J Clin Pract. 2012 Oct;66(10):924-39
22994327
Am J Geriatr Pharmacother. 2009 Dec;7(6):383-92
20129259
Phytother Res. 2011 Mar;25(3):381-6
20734324
Sci Rep. 2015 Dec 10;5:17475
26658160
Can Fam Physician. 2013 Aug;59(8):e372-8
23946044
Toxicol Appl Pharmacol. 2010 Mar 1;243(2):198-216
20018204
J Pharm Pharmacol. 2001 May;53(5):583-600
11370698
Ann Pharmacother. 2007 Jul;41(7):1124-9
17578882
J Ethnopharmacol. 2014 Dec 2;158 Pt B:507-10
24969823
Int J Risk Saf Med. 2015;27(2):55-65
26410008
Lancet. 2007 Aug 25;370(9588):657-66
17720017
Can J Clin Pharmacol. 2006 Summer;13(2):e240-50
16921199
J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):329-33
26681895
Patient Educ Couns. 2004 Apr;53(1):5-11
15062898
Hypertens Pregnancy. 2015 May;34(2):181-203
25549172
BMJ Open. 2014 Mar 28;4(3):e003431
24682573
Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005648
17943868
Cochrane Database Syst Rev. 2004;(1):CD000353
14973954
J Altern Complement Med. 2008 Dec;14(10):1263-9
19032071
Am J Ther. 2003 May-Jun;10(3):163-9
12756423
Int J Pharm Pract. 2009 Feb;17(1):31-8
20218027
Pharmacotherapy. 2012 Apr;32(4):354-82
22461123
PLoS One. 2012;7(9):e45196
23028841
Cochrane Database Syst Rev. 2003;(1):CD003803
12535487
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946
15846645
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Apr;35(4):394-400
26043559
Int J Occup Environ Health. 2015;21(4):303-7
25843124
Drug Test Anal. 2016 Mar-Apr;8(3-4):413-7
26768111
Arthritis Res Ther. 2012 Jan 30;14(1):201
22293240
Med Clin North Am. 2005 Nov;89(6):1225-57
16227061
Am J Health Syst Pharm. 1998 Jun 15;55(12):1266-7
9640465
Evid Based Complement Alternat Med. 2008 Dec;5(4):451-6
18955213
Am Fam Physician. 2006 Jan 15;73(2):283-90
16445274
J Am Board Fam Med. 2006 Nov-Dec;19(6):566-78
17090790
Can Fam Physician. 2013 Aug;59(8):e364-71
23946043
Med Sci Sports Exerc. 2013 Jan;45(1):23-8
22811037
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004845
19370613
Regul Toxicol Pharmacol. 2016 Apr;76:1-6
26776752
J Integr Med. 2015 Nov;13(6):356-62
26559360
Tex Heart Inst J. 2006;33(1):40-7
16572868
BMC Med. 2013 Oct 11;11:222
24120035
Phytother Res. 2011 Jun;25(6):892-6
21110397
CMAJ. 2011 Dec 13;183(18):2079
22083673
J Matern Fetal Neonatal Med. 2012 Dec;25(12):2570-4
22889274
Cochrane Database Syst Rev. 2013 Nov 13;(11):CD009710
24222383